| Quality ID #65 (NQF 0069): Appropriate Treatment for Upper Respiratory Infection (URI)
—National Quality Strategy Domain: Efficiency and Cost Reduction —Meaningful Measure Area: Appropriate Use of Healthcare |
2022 COLLECTION TYPE:
MIPS CLINICAL QUALITY MEASURES (CQMS)
MEASURE TYPE:
Process – High Priority
DESCRIPTION:
Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic dispensing event
INSTRUCTIONS:
This measure is to be submitted once for each occurrence of upper respiratory infection during the performance period. Claims data will be analyzed to determine unique occurrences. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.
NOTE: Patient encounters for this measure conducted via telehealth (e.g., encounters coded with GQ, GT, 95, or POS 02 modifiers) are allowable.
Measure Submission Type:
Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.
DENOMINATOR:
Outpatient visits, telephone visits, online assessments (i.e. e-visit or virtual check-in), observation stays or emergency department visits with a diagnosis of upper respiratory infection (URI) during the measurement period among patients 3 months of age and older.
Denominator Instructions:
This is an episode of care measure that examines all eligible episodes for the patient during the measurement period. If the patient has more than one episode in a 31-day period, include only the first episode.
DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.
Denominator Criteria (Eligible Cases):
Patients aged 3 months of age and older on date of encounter
AND
Diagnosis for URI (ICD-10-CM): J00, J06.0, J06.9
AND
Patient encounter during the performance period (CPT or HCPCS): 98966, 98967, 98968, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99218, 99217, 99219, 99220, 99281, 99282, 99283, 99284, 99285, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350,99381*, 99382*, 99383*, 99384*, 99385*, 99386*, 99387*, 99391*, 99392*, 99393*, 99394*, 99395*, 99396*, 99397*, 99401*, 99402*, 99403*, 99404*, 99411*, 99412*, 99441, 99442, 99443, 99455, 99456
AND NOT
DENOMINATOR EXCLUSIONS:
URI episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease): G2173
OR
URI episodes when the patient had an active prescription of antibiotics (Table 1) in the 30 days prior to the episode date: G2174
OR
URI episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, Lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or UTI, and acne): G8709
OR
Patients who use hospice services any time during the measurement period: G9700
Table 1 – Antibiotic Medications
Note: This list should be used when assessing antibiotic prescriptions for the denominator exclusion and numerator components.
| Description | Prescription | ||
| Aminopenicillins |
|
||
| Beta-lactamase inhibitors |
|
||
| First generation cephalosporins |
|
||
| Folate antagonist |
|
||
| Lincomycin derivatives |
|
||
| Macrolides |
|
||
| Natural penicillins |
|
||
| Penicillinase-resistant penicillins |
|
||
| Quinolones |
|
||
| Second generation cephalosporins |
|
||
| Sulfonamides |
|
||
| Tetracyclines |
|
||
| Third generation cephalosporins |
|
||
NUMERATOR:
URI episodes without a prescription for antibiotic medication (Table 1) on or 3 days after the outpatient visit, telephone visit, online assessment, observation stay or emergency department visit for an upper respiratory infection
Numerator Instructions:
For performance, the measure will be calculated as the number of patient’s encounter(s) where antibiotics from Table 1 were neither prescribed nor dispensed on or within three days of the episode for URI over the total number of encounters in the denominator. A higher score indicates appropriate treatment of patients with URI (e.g., the proportion for whom antibiotics were not prescribed or dispensed following the episode). Delayed prescriptions (where an antibiotic was prescribed and patient was instructed to delay taking the antibiotic) are considered “Performance Not Met”.
Numerator Options:
Performance Met: Patient not prescribed or dispensed antibiotic (G8708)
OR
Performance Not Met: Patient prescribed or dispensed antibiotic (G8710)